1-8 of 8
Jeffrey Weber
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Association of Tumor Microenvironment T-cell Repertoire and Mutational Load with Clinical Outcome after Sequential Checkpoint Blockade in Melanoma

Free
Erik Yusko, Marissa Vignali, Richard K. Wilson, Elaine R. Mardis, F. Stephen Hodi, Christine Horak, Han Chang, David M. Woods, Harlan Robins, Jeffrey Weber
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (3): 458–465.
https://doi.org/10.1158/2326-6066.CIR-18-0226
Published: 01 March 2019
View article titled, Association of Tumor Microenvironment T-cell Repertoire and Mutational Load with Clinical Outcome after Sequential Checkpoint Blockade in Melanoma
Open the PDF for Association of Tumor Microenvironment T-cell Repertoire and Mutational Load with Clinical Outcome after Sequential Checkpoint Blockade in Melanoma in another window
Includes: Supplementary data
Journal Articles

Abstract A067: PD-1 blockade enhances OX40 expression on regulatory T-cells and decreases suppressive function through induction of phospho-STAT3 signaling

Free
David M. Woods, Rupal Ramakrishnan, Andressa L. Sodré, Anders Berglund, Jeffrey Weber
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (11_Supplement): A067.
https://doi.org/10.1158/2326-6066.IMM2016-A067
Published: 31 October 2016
View article titled, Abstract A067: PD-1 blockade enhances OX40 expression on regulatory T-cells and decreases suppressive function through induction of phospho-STAT3 signaling
Journal Articles

Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after Ipilimumab

Free
Jeffrey Weber, Geoffrey Gibney, Ragini Kudchadkar, Bin Yu, Pingyan Cheng, Alberto J. Martinez, Jodie Kroeger, Allison Richards, Lori McCormick, Valerie Moberg, Heather Cronin, Xiuhua Zhao, Michael Schell, Yian Ann Chen
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (4): 345–353.
https://doi.org/10.1158/2326-6066.CIR-15-0193
Published: 31 March 2016
View article titled, Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after Ipilimumab
Open the PDF for Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after Ipilimumab in another window
Includes: Supplementary data
Journal Articles

Abstract A066: Histone deacetylase 11 is an epigenetic regulator of T-cell pro-inflammatory function and novel target for enhancing T-cell anti-tumor activity

Free
David M. Woods, Andressa L. Sodre, Karrune Woan, Alejandro Villagra, Amod Sarnaik, Jeffrey Weber, Eduardo M. Sotomayor
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (1_Supplement): A066.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-A066
Published: 03 January 2016
View article titled, Abstract A066: Histone deacetylase 11 is an epigenetic regulator of T-cell pro-inflammatory function and novel target for enhancing T-cell anti-tumor activity
Journal Articles

Abstract A074: Selective Inhibition of HDAC6 augments T-cell central memory and enhances anti-tumor functions: Implications in TIL therapy

Free
Andressa Sodre Laino, David M. Woods, Amod Sarnaik, Jeffrey Weber, Eduardo M. Sotomayor
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (1_Supplement): A074.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-A074
Published: 03 January 2016
View article titled, Abstract A074: Selective Inhibition of HDAC6 augments T-cell central memory and enhances anti-tumor functions: Implications in TIL therapy
Journal Articles

HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade

Free
David M. Woods, Andressa L. Sodré, Alejandro Villagra, Amod Sarnaik, Eduardo M. Sotomayor, Jeffrey Weber
Journal: Cancer Immunology Research
Cancer Immunol Res (2015) 3 (12): 1375–1385.
https://doi.org/10.1158/2326-6066.CIR-15-0077-T
Published: 06 December 2015
View article titled, HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade
Open the PDF for HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade in another window
Includes: Supplementary data
Journal Articles

Abstract B19: Targeting histone deacetylase 6 in T-cells to improve melanoma immunotherapy

Free
Andressa Sodre Laino, David M. Woods, Esteban Celis, Jeffrey Weber, Eduardo Sotomayor
Journal: Cancer Immunology Research
Cancer Immunol Res (2015) 3 (10_Supplement): B19.
https://doi.org/10.1158/2326-6074.TUMIMM14-B19
Published: 09 October 2015
View article titled, Abstract B19: Targeting histone deacetylase 6 in T-cells to improve melanoma immunotherapy
Journal Articles

Abstract PR09: Targeting histone deacetylase 6 in T-cells to improve melanoma immunotherapy

Free
Andressa Sodre Laino, David M. Woods, Esteban Celis, Jeffrey Weber, Eduardo Sotomayor
Journal: Cancer Immunology Research
Cancer Immunol Res (2015) 3 (10_Supplement): PR09.
https://doi.org/10.1158/2326-6074.TUMIMM14-PR09
Published: 09 October 2015
View article titled, Abstract PR09: Targeting histone deacetylase 6 in T-cells to improve melanoma immunotherapy